Q2 2026 Holdings
Filed 2026-08-12 | 86 holdings | $189.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alphabet Inc(GOOG) | Common | 02079K107 | $32.3M | 91,420 | 17.1% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $26.6M | 225,000 | 14.1% |
| Syndax Pharmaceutical, Inc.(SNDX) | Common | 87164F105 | $9.6M | 437,245 | 5.1% |
| Xeris Biopharma Holdings, Inc.(XERS) | Common | 98422E103 | $8.4M | 1,060,000 | 4.4% |
| Travere Therapeutics, Inc.(TVTX) | Common | 89422G107 | $8.4M | 147,282 | 4.4% |
| Protagonist Therapeutics, Inc(PTGX) | Common | 74366E102 | $7.7M | 63,000 | 4.1% |
| Bridgebio Pharma, Inc.(BBIO) | Common | 10806X102 | $6.9M | 92,850 | 3.7% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common | 462260100 | $6.7M | 1,600,000 | 3.5% |
| Alkermes PLC(ALKS) | Common | G01767105 | $6.4M | 121,759 | 3.4% |
| JPMorgan Chase & Co.(JPM) | Common | 46625H100 | $5.9M | 18,098 | 3.1% |
| Janus Henderson AAA CLO ETF(JAAA) | Common | 47103U845 | $4.7M | 93,528 | 2.5% |
| LPL Financial Holdings Inc. | Common | 52012V100 | $4.6M | 16,500 | 2.5% |
| Cogent Biosciences Inc.(COGT) | Common | 19240Q201 | $4.3M | 111,081 | 2.3% |
| TG Therapeutics, Inc.(TGTX) | Common | 88322Q108 | $3.7M | 66,839 | 1.9% |
| Catalyst Pharmaceuticals, Inc.(CLST) | Common | 14888L101 | $3.6M | 114,000 | 1.9% |
| Agios Pharmaceutical, Inc.(AGIO) | Common | 00847X104 | $3.5M | 95,058 | 1.9% |
| Viridian Therapeutics, Inc.(VRDN) | Common | 92790C104 | $3.3M | 181,000 | 1.8% |
| Relmada Therapeutics, Inc.(RLMD) | Common | 75955J402 | $3.1M | 451,000 | 1.6% |
| Arcus Biosciences, Inc.(RCUS) | Common | 03969F109 | $2.5M | 81,241 | 1.3% |
| Cybin Inc(HELP) | Common | 23256X407 | $2.4M | 370,000 | 1.3% |
| Spdr S&P Biotech ETF(XBI) | Common | 78464A870 | $2.4M | 15,000 | 1.3% |
| Rezolute, Inc.(RZLT) | Common | 76200L309 | $1.9M | 370,000 | 1.0% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.7M | 48,000 | 0.9% |
| Madrigal Pharmaaceuticals, Inc.(MDGL) | Common | 558868105 | $1.6M | 3,000 | 0.9% |
| AtriCure, Inc.(ATRC) | Common | 04963C209 | $1.4M | 51,400 | 0.8% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $1.4M | 2,670,850 | 0.7% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $1.3M | 263,168 | 0.7% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common | 90400D108 | $1.3M | 38,069 | 0.7% |
| The Panagram Bbb-B CLO ETF(CLOZ) | Common | 81752T528 | $1.3M | 47,807 | 0.7% |
| Cullinan Therapeutics, Inc.(CGEM) | Common | 230031106 | $1.3M | 69,182 | 0.7% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $1.3M | 4,922 | 0.7% |
| Vera Therapeutics, Inc.(VERA) | Common | 92337R101 | $1.1M | 26,000 | 0.6% |
| Orchestra Biomed Holdings, Inc.(OBIO) | Common | 68572M106 | $1.1M | 253,651 | 0.6% |
| Spruce Biosciences, Inc.(SPRB) | Common | 85209E208 | $1.1M | 20,000 | 0.6% |
| Connect Biopharma Holdings Limited(CNTB) | Common | G23549101 | $1.1M | 444,862 | 0.6% |
| iShares Biotechnology ETF(IBB) | Common | 464287556 | $1.0M | 5,500 | 0.6% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $864.2K | 4,000 | 0.5% |
| Pfizer Inc.(PFE) | Common | 717081103 | $778.7K | 32,337 | 0.4% |
| Apple Inc.(AAPL) | Common | 037833100 | $721.7K | 2,494 | 0.4% |
| Canadian Natural Resources Limited(CNQ) | Common | 136385101 | $663.6K | 16,800 | 0.4% |
| Pelthos Therapeutics, Inc.(PTHS) | Common | 171126204 | $623.8K | 22,073 | 0.3% |
| International Business Machines(IBM) | Common | 459200101 | $602.4K | 2,142 | 0.3% |
| Microsoft Corporation(MSFT) | Common | 594918104 | $596.8K | 1,600 | 0.3% |
| Verastem Inc.(VSTM) | Common | 92337C203 | $592.1K | 155,000 | 0.3% |
| Kura Oncology, Inc.(KURA) | Common | 50127T109 | $578.9K | 52,767 | 0.3% |
| Solid Bioscience Inc.(SLDB) | Common | 83422E204 | $561.5K | 56,208 | 0.3% |
| DuPont de Nemours, Inc. | Common | 36614N201 | $511.0K | 3,767 | 0.3% |
| Insmed Incorporated(INSM) | Common | 457669307 | $453.5K | 4,253 | 0.2% |
| LB Pharmaceuticals, Inc.(LBRX) | Common | 50180M108 | $420.8K | 12,965 | 0.2% |
| CareDx, Inc.(CDNA) | Common | 14167L103 | $388.5K | 13,630 | 0.2% |